Pfizer COVID vaccine approved in South Korea for 5-11 years old MD Bureau24 Feb 2022 10:00 AM ISTThe vaccine will help protect younger children from infections or serious illness amid South Korea's fast-developing omicron surge, the MDFS added.
South Korean company to develop combined vaccine for COVID, influenza MD Bureau23 Feb 2022 1:14 PM ISTSeoul: As 'flurona,' which means having both COVID-19 and influenza at the same time, is recently popping up in many countries, including Israel,...
Panacea Biotec, CEPI, THSTI partner to develop broadly protective Betacoronavirus vaccines MD Bureau23 Feb 2022 10:00 AM ISTNew Delhi: Panacea Biotec has recently announced a partnership with the Translational Health Science and Technology Institute (THSTI) and...
Biological E Corbevax gets DCGI nod for 12-18 years Ruchika Sharma22 Feb 2022 12:22 PM ISTThe CORBEVAX vaccine is administered through intramuscular route with two doses scheduled 28 days apart.
US FDA considers approving a second Covid-19 booster shot: Report MD Bureau21 Feb 2022 9:00 AM ISTNew Delhi: US health regulators are looking at authorizing a potential fourth dose of a Covid-19 vaccine in the fall, the Wall Street Journal reported...
GSK halts respiratory virus vaccine trial in pregnant women Ruchika Sharma19 Feb 2022 2:16 PM ISTLondon: GSK has paused a late-stage trial of its vaccine candidate against the respiratory syncytial virus (RSV) in pregnant women based on safety...
Moderna to develop mRNA-based vaccine for shingles Ruchika Sharma19 Feb 2022 12:41 PM ISTModerna's shingles vaccine is being developed to target the varicella-zoster virus.
Novavax COVID vaccine gets nod in Canada Ruchika Sharma18 Feb 2022 1:02 PM ISTGaithersburg: Novavax, Inc. has recently announced that Health Canada has granted authorization for Nuvaxovid COVID-19 Vaccine (Recombinant protein,...
BioNTech- Pfizer Omicron vaccine delayed, says BioNTech Chief Ugur Sahin Ruchika Sharma17 Feb 2022 3:25 PM ISTBerlin: Delivery of Pfizer and BioNTech SE's vaccine to combat the Omicron COVID-19 variant was delayed by several weeks due to a slower-than...
Omicron-specific booster could be ready by August: Moderna CEO Ruchika Sharma17 Feb 2022 2:45 PM ISTModerna's vaccines use mRNA technology to provoke an immune response, similar to the shot developed by Pfizer/BioNTech.
Study says three doses of Pfizer COVID vaccine better than two Ruchika Sharma16 Feb 2022 3:20 PM ISTWashington: A third dose of the Pfizer COVID-19 vaccine conferred higher effectiveness against infection and hospitalisation than two doses of...
Biological E Corbevax safe, offers high antibody levels: NTAGI Chairman Ruchika Sharma16 Feb 2022 12:39 PM ISTNew Delhi: India's third homegrown Covid-19 vaccine Corbevax is safe and offers good immunogenicity and higher antibody levels than some other vector...
